| 1-R13-EB037427-01 |
Optical Probes: Discovery to Application |
Evan Miller |
Federation of Amer Soc For Exper Biology |
| 5-R21-EB036323-02 |
Optimized and accessible immuno-PET using lipid nanoparticle-mediated in vivo bioreactor |
Sheung Chee Thomas Ng |
Massachusetts General Hospital |
| 1-F30-EB035471-01A1 |
Outer sphere tuning of a Eu(II)-containing contrast agent for imaging hypoxia via MRI |
Andrea Batchev |
Wayne State University |
| 1-R41-EB034168-01A1 |
Production of radiometal-based radiopharmaceuticals at a clinical scale via droplet-scale radiochemistry |
Jason Jones |
Dropletpharm Inc. |
| 5-R00-EB030602-05 |
Quantification of whole-body distribution and speciation of gadolinium-based contrast agents by Y-86 PET/MRI |
Mariane Le Fur |
Massachusetts General Hospital |
| 1-R01-EB036468-01 |
Quantitative Dynamic Monitoring of MSCs and MSC-EVs in a Mouse Model of Intracerebral Hemorrhage |
Shreyas Kuddannaya |
University of Miami School of Medicine |
| 2-R01-EB029418-05A1 |
Radiopaque 3D printed tissue engineered scaffolds for nerve generation |
Erik Shapiro |
Henry Ford Health + Michigan State University Health Sciences |
| 5-R21-EB033872-02 |
Rapid low-cost production of contrast agents for metabolic imaging |
Eduard Chekmenev |
Wayne State University |
| 5-R01-EB033377-03 |
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses |
Jing Jin |
Northwestern University at Chicago |
| 5-P41-EB024495-07 |
Resource for Molecular Imaging Agents in Precision Medicine |
Martin Pomper |
Ut Southwestern Medical Center |
